CVD/HPHT Lab-Grown Disclosure
CVD/HPHT Lab-Grown Disclosure
Regulatory frameworks, trade obligations, and the ethics of origin transparency in the laboratory-diamond market
The disclosure of laboratory-grown diamonds — whether produced by chemical vapour deposition (CVD) or high-pressure high-temperature (HPHT) synthesis — is one of the most consequential regulatory developments in the modern gem trade. Because laboratory-grown diamonds are chemically, physically, and optically identical to their natural counterparts (both are crystalline carbon, with the same refractive index of approximately 2.417, the same hardness of 10 on the Mohs scale, and the same thermal conductivity), the only reliable means by which a consumer can distinguish them is through explicit, accurate disclosure at the point of sale. Regulatory bodies in the United States, the European Union, and international trade organisations have progressively tightened the language and placement requirements for such disclosure, making it a live and evolving area of compliance for retailers, wholesalers, grading laboratories, and online marketplaces alike.
The Regulatory Landscape
In the United States, the primary authority is the Federal Trade Commission (FTC), whose Jewellery Guides (Guides for the Jewelry, Precious Metals, and Pewter Industries) were substantially revised in 2018. The revised Guides removed the word "synthetic" from the FTC's own preferred terminology — acknowledging that the term had become potentially misleading, since it implies inferiority or artificiality in a material that is chemically genuine diamond — but they simultaneously reinforced the obligation to disclose laboratory origin clearly and conspicuously. Under the 2018 Guides, acceptable descriptors include laboratory-grown, laboratory-created, and [manufacturer name]-created, as well as synthetic if used without deceptive intent. The unqualified word "diamond," standing alone in a trade context, remains permissible only for natural diamonds. Any use of "diamond" in reference to a laboratory-grown stone must be immediately preceded or followed by a qualifying term, in type of equal or greater size and in equal or greater prominence.
The FTC's position also clarified that terms such as "real," "genuine," "natural," or "precious" may not be applied to laboratory-grown diamonds in ways that imply natural origin. Conversely, the Guides explicitly state that a laboratory-grown diamond is not a simulant: it is not cubic zirconia, moissanite, or glass, and must not be conflated with those materials. This distinction is commercially significant, as it acknowledges the genuine gemological status of laboratory-grown diamonds while preserving the consumer's right to know their origin.
Internationally, CIBJO (the World Jewellery Confederation) addresses laboratory-grown diamonds in its Diamond Blue Book, requiring that all synthetic diamonds be described with a clear qualifier — "synthetic," "laboratory-grown," or "laboratory-created" — immediately adjacent to the word "diamond" in all commercial communications, grading reports, and invoices. CIBJO's position aligns with that of the International Diamond Council (IDC) and the World Diamond Council (WDC), both of which have issued guidance reinforcing that origin disclosure is non-negotiable regardless of the material's chemical equivalence to natural diamond.
Grading Laboratory Practice
The major independent grading laboratories have adopted disclosure standards that reflect and in some cases exceed regulatory minimums. The Gemological Institute of America (GIA) issues dedicated Laboratory-Grown Diamond Reports, which are visually distinct from its Natural Diamond Reports in colour and layout; the reports state "Laboratory-Grown" prominently on their face and do not use the traditional GIA colour and clarity grading scale in the same format, instead describing colour and clarity ranges rather than assigning letter grades, a distinction the GIA introduced in 2019 to reduce direct comparability with natural-diamond grading. The International Gemological Institute (IGI) and HRD Antwerp similarly issue separate report types for laboratory-grown diamonds, with explicit origin statements on the certificate face.
Laser inscription has become standard practice: most grading laboratories inscribe the girdle of laboratory-grown diamonds with the report number and the words "Lab Grown" or "LG," providing a permanent, physically verifiable disclosure that persists through resale. This is particularly important in the secondary market, where a stone may change hands multiple times and paper documentation may be lost.
Detection and Verification
The practical enforceability of disclosure requirements depends on the ability to detect laboratory origin. For CVD diamonds, characteristic features include strain patterns visible under cross-polarised light, the presence of non-diamond carbon inclusions, and distinctive photoluminescence signatures detectable by spectroscopy. HPHT diamonds often display metallic flux inclusions (typically iron-nickel alloys from the growth capsule), a cuboctahedral or cubic crystal habit, and specific nitrogen aggregation states detectable by infrared spectroscopy. Both types may exhibit anomalous fluorescence under ultraviolet light — CVD stones frequently show orange fluorescence under short-wave UV, a feature essentially absent in natural diamonds.
Automated screening devices, including the De Beers Group's DiamondView and GIA's iD100, are now widely deployed at the trade level to sort natural from laboratory-grown diamonds before grading or sale. These instruments use UV fluorescence imaging and photoluminescence spectroscopy to flag stones for further examination. The proliferation of such devices has made undisclosed laboratory-grown diamonds increasingly difficult to pass through reputable trade channels, though the risk of undisclosed stones entering the market — particularly in melee sizes below 0.10 ct, where individual testing is economically impractical — remains a documented concern.
Market Context and Commercial Implications
The commercial stakes of disclosure are substantial. Laboratory-grown diamonds have traded at significant discounts to natural diamonds of equivalent graded quality — discounts that have widened considerably since approximately 2020 as production capacity increased and wholesale prices for laboratory-grown stones declined sharply. A consumer who unknowingly purchases a laboratory-grown diamond at a price reflecting natural-diamond value suffers a direct financial harm, which is the core consumer-protection rationale for mandatory disclosure.
Conversely, a segment of the market actively prefers laboratory-grown diamonds on ethical or environmental grounds, and for these consumers, accurate disclosure is equally essential — they must be confident that a stone described as laboratory-grown is genuinely so, rather than a natural diamond being misrepresented in the opposite direction. Both failure modes — undisclosed laboratory-grown stones sold as natural, and natural stones misrepresented as laboratory-grown — constitute deceptive trade practice under FTC guidance.
The trade has also grappled with disclosure in the context of mixed parcels, where laboratory-grown and natural diamonds may be processed together, and in the context of treatments applied to laboratory-grown stones (such as post-growth HPHT annealing to improve colour in CVD diamonds). The latter raises a secondary disclosure question: a CVD diamond that has been HPHT-treated to achieve a better colour grade carries two origin/treatment disclosures, both of which are required by responsible grading practice.
Terminology Disputes and Ongoing Controversy
The terminology debate has been one of the more contentious aspects of this regulatory area. The natural-diamond industry, led principally by the Natural Diamond Council and its predecessor bodies, has consistently advocated for the retention of "synthetic" as the mandatory qualifier, arguing that it most clearly signals non-natural origin to consumers. Laboratory-grown diamond producers and their trade associations have argued that "synthetic" carries a pejorative connotation inconsistent with the material's genuine diamond composition, and have lobbied for "laboratory-grown" or "laboratory-created" as the standard. The FTC's 2018 revision accommodated both positions by permitting multiple qualifiers, but the underlying tension between the two industry segments has not been fully resolved.
Marketing language has also been a source of regulatory scrutiny. Phrases such as "above-ground diamond," "cultured diamond," "grown diamond," and "pure grown diamond" have been used by laboratory-grown diamond producers; the FTC has indicated that such terms are acceptable only when accompanied by a clear statement of laboratory origin, and that they may not substitute for the required qualifier. The use of "cultured" in particular has drawn scrutiny, as it echoes the terminology of cultured pearls — a natural-origin product — and may create consumer confusion about the nature of the growth process.
Obligations Across the Supply Chain
Disclosure obligations apply at every level of the supply chain, not solely at retail. Manufacturers, wholesalers, and importers are required to disclose laboratory origin in business-to-business transactions, on invoices, and in trade communications. Online marketplaces that list diamonds are expected to ensure that product listings accurately describe origin. Auction houses selling laboratory-grown diamonds in their jewellery sales are similarly obligated, and several major houses have adopted explicit policies requiring consignors to disclose laboratory origin and reflecting that origin in catalogue descriptions and lot estimates.
Failure to disclose — whether through omission, ambiguous language, or the use of prohibited unqualified terminology — exposes sellers to FTC enforcement action, civil liability, and reputational damage. Several enforcement actions and consent orders in the United States have addressed undisclosed or inadequately disclosed laboratory-grown diamonds, reinforcing that the FTC regards this as an active compliance priority rather than a theoretical concern.